Sanofi (SNY) Return on Sales (2009 - 2026)

Sanofi (SNY) has 18 years of Return on Sales data on file, last reported at 0.0% in Q1 2026.

• Quarterly Return on Sales changed 0.0% year-over-year to 0.0% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.0% (changed 0.0% YoY) and the FY2025 annual result came in at 0.0%, changed 0.0% from the prior year.
• Return on Sales retreated to 0.0% in Q1 2026 per SNY's latest filing, from 0.0% in the prior quarter.
• The five-year high for Return on Sales was 0.02% in Q4 2022, with the low at 0.0% in Q4 2024.
• Average Return on Sales over 5 years is 0.01%, with a median of 0.0% recorded in 2025.
• Year-over-year, Return on Sales advanced 2 bps in 2022 and retreated 2 bps in 2023.
• Sanofi's Return on Sales stood at 0.02% in 2022, then plunged by 101 bps to 0.0% in 2023, then sank by 171 bps to 0.0% in 2024, then jumped by 1307 bps to 0.0% in 2025, then sank by 99 bps to 0.0% in 2026.
• Business Quant data shows SNY's Return on Sales at 0.0% in Q1 2026, 0.0% in Q4 2025, and 0.0% in Q3 2025.